JP2011519292A5 - - Google Patents

Download PDF

Info

Publication number
JP2011519292A5
JP2011519292A5 JP2011504554A JP2011504554A JP2011519292A5 JP 2011519292 A5 JP2011519292 A5 JP 2011519292A5 JP 2011504554 A JP2011504554 A JP 2011504554A JP 2011504554 A JP2011504554 A JP 2011504554A JP 2011519292 A5 JP2011519292 A5 JP 2011519292A5
Authority
JP
Japan
Prior art keywords
functional group
group
cation
acid
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011504554A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011519292A (ja
Filing date
Publication date
Priority claimed from FR0854621A external-priority patent/FR2933306B1/fr
Priority claimed from FR0857560A external-priority patent/FR2937863B1/fr
Application filed filed Critical
Priority claimed from PCT/IB2009/005235 external-priority patent/WO2009127940A1/fr
Publication of JP2011519292A publication Critical patent/JP2011519292A/ja
Publication of JP2011519292A5 publication Critical patent/JP2011519292A5/ja
Pending legal-status Critical Current

Links

JP2011504554A 2008-04-14 2009-04-14 成長因子／両親媒性ポリマー複合体、可溶性のカチオン塩及び有機支持体を含有する骨形成組成物 Pending JP2011519292A (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US7113108P 2008-04-14 2008-04-14
US61/071,131 2008-04-14
US12901208P 2008-05-30 2008-05-30
US61/129,012 2008-05-30
FR0854621A FR2933306B1 (fr) 2008-07-07 2008-07-07 Composition osteogenique comprenant un complexe facteur de croissance polysaccharide anionique, un sel soluble de cation et une matrice organique
FR0854621 2008-07-07
US12961608P 2008-07-08 2008-07-08
US61/129,616 2008-07-08
US19321608P 2008-11-06 2008-11-06
FR0857560A FR2937863B1 (fr) 2008-11-06 2008-11-06 Composition osteogenique comprenant un complexe facteur de croissance polysaccharide anionique, un sel soluble de cation et un gel
US61/193,216 2008-11-06
FR0857560 2008-11-06
PCT/IB2009/005235 WO2009127940A1 (fr) 2008-04-14 2009-04-14 Composition osteogenique comprenant un complexe facteur de croissance/polymere amphiphile un sel soluble de cation e un support organique

Publications (2)

Publication Number Publication Date
JP2011519292A JP2011519292A (ja) 2011-07-07
JP2011519292A5 true JP2011519292A5 (https=) 2012-06-07

Family

ID=40791051

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011504554A Pending JP2011519292A (ja) 2008-04-14 2009-04-14 成長因子／両親媒性ポリマー複合体、可溶性のカチオン塩及び有機支持体を含有する骨形成組成物

Country Status (12)

Country Link
US (2) US20090291114A1 (https=)
EP (1) EP2288370A1 (https=)
JP (1) JP2011519292A (https=)
KR (1) KR20110014588A (https=)
CN (1) CN102065882A (https=)
AU (1) AU2009237414A1 (https=)
BR (1) BRPI0906553A2 (https=)
CA (1) CA2720203A1 (https=)
IL (1) IL208139A0 (https=)
MX (1) MX2010011267A (https=)
WO (1) WO2009127940A1 (https=)
ZA (1) ZA201006627B (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948573B1 (fr) * 2009-07-31 2011-11-18 Adocia Nouvelle forme d'administration de complexes de proteines osteogeniques
FR2975099A1 (fr) * 2011-05-10 2012-11-16 Adocia Polysaccharides a degre de fonctionnalisation modulable
FR2943538B1 (fr) 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
FR2980796B1 (fr) * 2011-09-30 2014-07-04 Adocia Oligosaccharides fonctionnalises
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
FR2952375A1 (fr) 2009-11-10 2011-05-13 Adocia Polysaccharides comportant des groupes fonctionnels carboxyles substitues par esterification par un derive d'alcool hydrophobe
FR2956116A1 (fr) * 2010-02-09 2011-08-12 Adocia Complexes polysaccharide/bmp-7 solubles a ph physiologique
FR2958646B1 (fr) 2010-04-07 2012-05-18 Adocia Polysaccharides comportant des groupes fonctionnels carboxyles substitues par un derive d'acide hydrophobe.
WO2011098962A2 (fr) * 2010-02-09 2011-08-18 Adocia Polysaccharides anioniques fonctionnalisés par au moins deux groupements hydrophobes portés par un spacer au moins trivalent
FR2958647B1 (fr) 2010-04-08 2013-08-23 Adocia Polysaccharides comportant des groupes fonctionnels carboxyles substitues par un derive hydrophobe porte par un spacer au moins trivalent.
WO2012153071A2 (fr) * 2011-05-10 2012-11-15 Adocia Polysaccharides à degré de fonctionnalisation modulable
WO2012153070A1 (fr) * 2011-05-10 2012-11-15 Adocia Oligosaccharides fonctionnalisés
FR2984749A1 (fr) * 2011-12-23 2013-06-28 Adocia Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 en combinaison avec une hormone gastro-intestinale a visee therapeutique
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
KR102000041B1 (ko) 2011-12-29 2019-07-16 엘지디스플레이 주식회사 발광표시장치 및 그 구동방법
KR101364704B1 (ko) * 2012-06-12 2014-02-20 순천향대학교 산학협력단 골 재생을 위한 다공성 하이드로젤 지지체의 제조방법
EP2919804B1 (fr) 2012-11-13 2018-01-31 Adocia Formulation à action rapide d'insuline comprenant un composé anionique substitué
US9359417B2 (en) 2013-01-25 2016-06-07 Warsaw Orthopedic, Inc. Cell cultures and methods of human recombinant growth and differentiaton factor-5 (rhGDF-5)
US8945872B2 (en) 2013-01-25 2015-02-03 Warsaw Orthopedic, Inc. Methods of purifying human recombinant growth and differentiation factor-5 (rhGDF-5) protein
US9051389B2 (en) 2013-01-25 2015-06-09 Warsaw Orthopedic, Inc. Expression conditions and methods of human recombinant growth and differentiation factor-5 (rhGDF-5)
US9169308B2 (en) 2013-01-25 2015-10-27 Warsaw Orthopedic, Inc. Methods and compositions of human recombinant growth and differentiation factor-5 (rhGDF-5) isolated from inclusion bodies
US8956829B2 (en) 2013-01-25 2015-02-17 Warsaw Orthopedic, Inc. Human recombinant growth and differentiaton factor-5 (rhGDF-5)
KR101429857B1 (ko) * 2013-06-19 2014-08-13 순천향대학교 산학협력단 골 지혈작용을 위한 복합이중층 섬유매트의 제조방법
NZ721597A (en) * 2013-12-24 2022-07-01 Ares Trading Sa Fgf-18 formulation in alginate/collagen hydrogels
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
WO2016127253A1 (en) * 2015-02-09 2016-08-18 Spatafora Michael Method and system for enhancing the activity of bone morphogenetic proteins
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
CN108690205A (zh) * 2018-05-28 2018-10-23 深圳市第二人民医院 一种ⅱ型胶原和聚丙烯酰胺复合水凝胶及其制备和应用
CN110368519B (zh) * 2019-08-26 2021-09-21 浙江瑞谷生物科技有限公司 一种基于贻贝粘蛋白的骨科粘合剂
WO2022216691A1 (en) * 2021-04-06 2022-10-13 Boston Scientific Scimed Inc. Therapeutic hydrogels
CN113563493B (zh) * 2021-07-01 2022-06-24 蚌埠医学院 疏水化多糖及其制备方法与应用
CN113662961B (zh) * 2021-07-19 2023-05-12 上海市第十人民医院 一种可捕获镁离子的微流控水凝胶微球及制备方法与应用
CN117757705B (zh) * 2023-04-28 2024-12-20 元素驱动(杭州)生物科技有限公司 可实现支链氨基酸联产的基因工程菌株的构建及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573251B2 (en) * 1994-03-30 2003-06-03 Denis Barritault Drug and pharmaceutical composition for the treatment of lesions of the nervous system and fractions enriched in heparan sulfate
US20040132653A1 (en) * 1997-01-30 2004-07-08 Biopharm Gmbh Lyophilized composition of bone morphogenetic factor human MP52
FR2781485B1 (fr) * 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
JP4548623B2 (ja) * 1999-02-24 2010-09-22 多木化学株式会社 生体材料
AU3556400A (en) * 1999-03-17 2000-10-04 Novartis Ag Pharmaceutical compositions
PL351948A1 (en) * 1999-06-04 2003-07-14 Alza Corp Implantable gel compositions and method of making thereof
FR2794649B1 (fr) * 1999-06-11 2003-04-11 Solutions Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
US7033603B2 (en) * 1999-08-06 2006-04-25 Board Of Regents The University Of Texas Drug releasing biodegradable fiber for delivery of therapeutics
US20050244393A1 (en) * 1999-12-22 2005-11-03 Henogen S.A. Sealant or tissue generating product
BR0310087A (pt) * 2002-05-17 2005-08-16 Wyeth Corp Veìculos sólidos injetáveis para ácido hialurÈnico para aplicação de proteìnas osteogênicas
FR2840614B1 (fr) * 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
ES2380340T3 (es) * 2003-12-05 2012-05-10 Northwestern University Anfífilos peptídicos auto-ensamblantes y métodos relacionados para la administración de factores de crecimiento
US8691273B2 (en) * 2005-07-21 2014-04-08 Lisopharm Ag Method for producing hydroxyapatite particles
JP2007037378A (ja) * 2005-07-29 2007-02-08 Pioneer Electronic Corp スイッチング電源の停電検出回路
FR2914305B1 (fr) * 2007-03-29 2009-07-03 Proteins & Peptides Man Dextran fonctionnalise par des amino-acides hydrophobes.
FR2891149B1 (fr) * 2005-09-26 2007-11-30 Biodex Sarl Composition pharmaceutique a action cicatrisante comprenant un derive de dextrane soluble et un facteur de croissance derive des plaquettes.
US20070178159A1 (en) * 2006-01-30 2007-08-02 Alza Corporation In-Situ Forming Porous Scaffold
US20070184087A1 (en) * 2006-02-06 2007-08-09 Bioform Medical, Inc. Polysaccharide compositions for use in tissue augmentation
JP2009532552A (ja) * 2006-04-07 2009-09-10 アドシア 二官能化された多糖類
US20080147197A1 (en) * 2006-12-14 2008-06-19 Mckay William F Biodegradable osteogenic porous biomedical implant with impermeable membrane
FR2919188B1 (fr) * 2007-07-27 2010-02-26 Proteins & Peptides Man Complexes entre un polymere amphiphile et une proteine osteogenique appartenant a la famille des bmps

Similar Documents

Publication Publication Date Title
JP2011519292A5 (https=)
AU2009302160B2 (en) Polysaccharides containing carboxyl functional groups substituted by a hydrophobic alcohol derivative
JP2012509303A5 (https=)
JP5486925B2 (ja) 疎水性アミノ酸により官能基化されたデキストラン
JP2010534708A5 (https=)
US9493583B2 (en) Anionic polysaccharides functionalized by a hydrophobic acid derivative
US6235726B1 (en) Water insoluble derivatives of polyanionic polysaccharides
US20120295833A1 (en) Polysaccharides having an adjustable degree of functionalization
CA2394582A1 (en) Water insoluble derivatives of polyanionic polysaccharides
WO2011070948A1 (ja) 精製ヒアルロン酸類の製造方法
JP6840683B2 (ja) 硫酸化多糖類の誘導体，ならびにその調製，修飾及び使用方法
US11203649B2 (en) Functionalized hyaluronic acid or a derivative thereof in the treatment of inflammatory states
US8426382B2 (en) Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative
JP6648142B2 (ja) グリコサミノグリカンおよびタンパク質を含む組成物
EP3956367A1 (en) Crosslinked polymer of functionalized hyaluronic acid and its use in the treatment of inflammatory states
Dedhia et al. Amine Modification
JP2018123241A (ja) 変性多糖およびその用途
JP2019025132A (ja) 変性多糖を含有する組成物およびその用途